Ren Keyu, Yong Chunming, Jin Yanchun, Rong Shanwei, Xue Kuijin, Cao Bin, Wei Hongyun
Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Department of Emergency, The Affiliated Hospital of Qingdao University, Qingdao, China.
Front Nutr. 2025 Feb 10;12:1519974. doi: 10.3389/fnut.2025.1519974. eCollection 2025.
Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by persistent inflammation of the colon. Recent research has highlighted the significant role of gut microbiota in the pathogenesis and treatment of UC. This review aims to provide a comprehensive overview of the current understanding of the relationship between gut microbiota and UC. We discuss the involvement of gut microbiota in the onset of UC, including the dysbiosis observed in patients and its potential mechanisms. Additionally, the role of extra-intestinal microbiota in UC pathogenesis is explored, which has been less studied but is gaining attention. The influence of gut microbiota on the efficacy of biological immunotherapy for UC is also examined, highlighting how microbial composition can influence treatment outcomes. Furthermore, we review microbiota transplantation, and their potential benefits in UC management. Finally, we consider the combined use of antibiotics and biological agents in UC treatment, discussing their synergistic effects and potential drawbacks. This review underscores the importance of gut microbiota in UC and suggests that targeting microbial communities could offer new avenues for effective treatment.
溃疡性结肠炎(UC)是一种慢性炎症性肠病,其特征为结肠持续炎症。最近的研究突出了肠道微生物群在UC发病机制和治疗中的重要作用。本综述旨在全面概述目前对肠道微生物群与UC之间关系的理解。我们讨论了肠道微生物群在UC发病中的作用,包括在患者中观察到的微生物群失调及其潜在机制。此外,还探讨了肠道外微生物群在UC发病机制中的作用,这方面的研究较少,但正受到关注。还研究了肠道微生物群对UC生物免疫治疗疗效的影响,强调了微生物组成如何影响治疗结果。此外,我们回顾了微生物群移植及其在UC管理中的潜在益处。最后,我们考虑在UC治疗中联合使用抗生素和生物制剂,讨论它们的协同作用和潜在缺点。本综述强调了肠道微生物群在UC中的重要性,并表明针对微生物群落可能为有效治疗提供新途径。